5-chloro-3-(4-methanesulfonylphenyl)-6' -methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis

Details for Australian Patent Application No. 2001264804 (hide)

Owner Merck & Co., Inc.

Inventors Davies, Ian W.; Crocker, Louis S.; Kotliar, Andrew; Osifchin, Richard G.

Agent Spruson & Ferguson

Pub. Number AU-B-2001264804

PCT Pub. Number WO01/92230

Priority 60208017 26.05.00 US

Filing date 22 May 2001

Wipo publication date 11 December 2001

Acceptance publication date 6 April 2006

International Classifications

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/444 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

6 April 2006 Application Accepted

  Published as AU-B-2001264804

3 August 2006 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001264805

2001264803